Neil Graham

Neil Graham is an expert leader in biopharma medicine development with a notable background in antiviral and immunology drug development. Currently serving as a Non Executive Director at Allakos Inc, ZuraBio, ASLAN Pharmaceuticals, and Pharmaxis/Syntara, Neil provides oversight and strategic guidance across multiple organizations. As a Biopharma Development Consultant at Biopharma Medicines Development LLC since January 2020, Neil brings extensive experience that includes a significant tenure as VP Immunology and Inflammation at Regeneron Pharmaceuticals, where leadership in the development of Dupixent was key. Previous roles include Chief Medical Officer at Tiziana Life Sciences, regulatory and clinical responsibilities at Trimeris, and a focus on HCV and HBV at XTL Biopharmaceuticals. Neil Graham holds an MD, MPH, and MBBS from the University of Adelaide.